Delivery Order SPE2DB24D2102-SPE2DB24FJHLY

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $70,711.90 Firm Fixed Price Delivery Order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a specialty medication, with a completion date of May 23, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.40 firm fixed price delivery order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through February 26, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $20,322.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of DROXIDOPA 300 MG CAPSULE 90S, a specialty medication. The contract has an ultimate completion date of April 21, 2023 and utilizes a firm fixed-price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $60,045.24 and is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 22, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $15,230.71 and is a delivery order for the supply of 4566601202 - DROXIDOPA 100 MG CAPSULE 90S. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,467.79, is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $16,195.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566803424 DROXIDOPA 300 MG CAPSULE 90S, a specialty medication, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DROXIDOPA 100 MG CAPSULE 90S. The contract, valued at $21,319.00, is a Firm Fixed Price Delivery Order with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a ceiling value of $37,579.10 and a performance period through March 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This federal contract award is for the delivery of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,905.57, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a...
  • SPE2DB24D2102
    Indefinite Delivery Contract
  • SPE2DB24D2102-SPE2DB24FJHLY
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,689.89 firm-fixed-price delivery order is for the supply of DROXIDOPA 300 MG CAPSULE 90S, a medication used for the treatment of certain medical conditions. The contract has an ultimate completion date of June 14, 2024.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries. The award reviewed does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:16 AM